Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Xcyte Digital Corp. Signs Agreement to Purchase Assets of Webinar.net (click to learn more) Viva Gold Reports Multiple High-Grade Gold Hits at the Tonopah Gold Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Healthcare Biotechnology
Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care... see more

Recent & Breaking News (TSXV:COV)

Covalon Announces Voting Results from Fiscal 2023 Annual Meeting of Shareholders

Business Wire March 7, 2024

Covalon To Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024

Business Wire February 28, 2024

Covalon Announces First Quarter Fiscal 2024 Results

Business Wire February 28, 2024

Covalon Announces Management Changes

Business Wire January 26, 2024

Covalon Announces Fourth Quarter and Year End Results for Fiscal 2023

Business Wire January 26, 2024

Covalon Technologies Ltd. Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO

Business Wire January 4, 2024

Covalon's VALGuard Gains Prestigious Recognition in the British Journal of Nursing

Business Wire November 15, 2023

Covalon Announces Issuance of Deferred Share Units

Business Wire October 20, 2023

Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR

Business Wire October 13, 2023

Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago

Business Wire October 11, 2023

Covalon Announces Leadership Changes

Business Wire September 26, 2023

Life with a Central Line [WEBINAR]: Key Considerations from the Patient's Perspective

Business Wire September 25, 2023

Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference

Business Wire September 19, 2023

Covalon Announces Third Quarter Fiscal 2023 Results

Business Wire August 16, 2023

Covalon Announces Conference Call to Discuss Third Quarter Fiscal 2023 Financial Results

Business Wire August 14, 2023

Premier Medical Journal Spotlights Covalon's VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites

Business Wire July 18, 2023

Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 - 30, 2023

Business Wire June 27, 2023

Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 - 28, 2023 in Orlando, Florida

Business Wire June 26, 2023

Webinar on Addressing MARSI in Vascular Access: The Role of Skin Integrity in Infection Prevention, Presented by Covalon

Business Wire June 21, 2023

Breakthrough Solution for Fragile Skin: Covalon's IV Clear® Dressing Recommended by Physicians at a Top 10 U.S. Children's Hospital and Epidermolysis Bullosa Center of Excellence

Business Wire June 13, 2023